4 citations
,
January 2025 in “JAAD reviews.” This literature review found that pediatric patients with vitiligo may have increased risks of conditions such as atopic dermatitis, alopecia areata, autoimmune thyroid disease, and psychiatric disorders, impacting their quality of life. Screening should consider these risks for effective management.
14 citations
,
April 2016 in “British Journal of Dermatology” This study found that a combined pattern of repigmentation was most commonly observed in vitiligo, with a new 'medium spotted' pattern proposed for areas with few hair follicles.
May 2023 in “Dermatology online journal” This review summarizes the psychosocial impact of common pediatric skin conditions like vitiligo, psoriasis, and alopecia areata, highlighting increased risks of anxiety, depression, and quality of life impairment for affected children and their caregivers, and underscores the need for improved support and research on interventions.
March 2026 in “Clinical Cosmetic and Investigational Dermatology” This research found that combining a 308-nm excimer laser with oral compound glycyrrhizin and topical 0.03% tacrolimus was more effective for treating pediatric facial and cervical vitiligo, resulting in faster and higher rates of repigmentation with minimal adverse effects compared to glycyrrhizin and tacrolimus alone.
This study conducted at a Moroccan tertiary dermatology center describes the characteristics of pediatric lichen, highlighting that dermoscopy can improve diagnostic accuracy by identifying distinct patterns across clinical variants, with lichen sclerosus being the most frequent subtype among the children studied.
